Resources
Laboratory Policies and Procedures 02 17 2025
Laboratory Policies and Procedures1
Bone Marrow Requisition Quest Version
NMMC Pathology
Overview Letter
Department of Pathology
Personnel
Accreditation and Licensure
Policies & Specimen Collection Information
Policies-Specimen Collection and Preparation – NMMC
Specimen Packaging and Courier Services
Patient Preparation
Minimum Blood Amounts Needed
Collection of Blood Specimens by Venipuncture
Collection of Blood Specimens by Skin Puncture
Collection of Urine Specimens
Instruction for the Proper Collection and Handling of Culture Specimens
Specimens for Microbiology
Guidelines for Stool Cultures for Diagnostic Testing
Cytology Specimen Collection
Tissue Examination
Point of Care (POC) Testing
Therapeutic Drug Monitoring (TDM) Recommended Collection Times for Peak Trough
Proper Labeling of Laboratory Specimens
Test Collection Protocols
NMMC AFP Form
Semen Analysis Info Form
Spanish Semen Collection Instructions
Laboratory Policies and Procedures 02 17 2025
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
PREV
1 of 80
2 of 80
3 of 80
4 of 80
5 of 80
6 of 80
7 of 80
8 of 80
9 of 80
10 of 80
11 of 80
12 of 80
13 of 80
14 of 80
15 of 80
16 of 80
17 of 80
18 of 80
19 of 80
20 of 80
21 of 80
22 of 80
23 of 80
24 of 80
25 of 80
26 of 80
27 of 80
28 of 80
29 of 80
30 of 80
31 of 80
32 of 80
33 of 80
34 of 80
35 of 80
36 of 80
37 of 80
38 of 80
39 of 80
40 of 80
41 of 80
42 of 80
43 of 80
44 of 80
45 of 80
46 of 80
47 of 80
48 of 80
49 of 80
50 of 80
51 of 80
52 of 80
53 of 80
54 of 80
55 of 80
56 of 80
57 of 80
58 of 80
59 of 80
60 of 80
61 of 80
62 of 80
63 of 80
64 of 80
65 of 80
66 of 80
67 of 80
68 of 80
69 of 80
70 of 80
71 of 80
72 of 80
73 of 80
74 of 80
75 of 80
76 of 80
77 of 80
78 of 80
79 of 80
80 of 80
NEXT
Test Code
Test Name
15273
CAH Panel 3 (Aldosterone Synthase Deficiency)
15269
CAH Panel 1 (21-Hydroxylase vs 11Beta-Hydroxylase Deficiency)
16072
CAH (21-Hydroxylase Deficiency) Gene Sequencing
91680
CAH (21-Hydroxylase Deficiency) Common Mutations, Fetal Cells
14755
CAH (21-Hydroxylase Deficiency) Common Mutations
305
Caffeine
672
Cadmium, Random Urine
299
Cadmium, Blood
36434
Cadmium, 24-Hour Urine
26328
Cabbage (f216) IgE [2632X]
19293
CA19-9, IHC without Interpretation [19293X]
191388
CA19-9, IHC with Interpretation [19138X]
19292
CA125, IHC without Interpretation [19292X]
191378
CA125, IHC with Interpretation [19137X]
17419
CA 27.29, CSF
29493
CA 27.29
17642
CA 19-9, Pleural Fluid
17638
CA 19-9, Peritoneal Fluid
17643
CA 19-9, Pericardial Fluid
17417
CA 19-9, CSF
4698
CA 19-9
5819
CA 15-3
17717
CA 125 with HAMA Treatment
21382
CA 125 [29256X]
90196
C4d, IHC without Interpretation
90146
C4d, IHC with Interpretation
17689
C3a desArg Fragment
137182
C3 Nephritic Factor, Serum [10287X]
298
C1 Esterase Inhibitor, Protein
297
C1 Esterase Inhibitor, Functional
8592
Bupropion and Metabolite, Serum/Plasma
16314
Buprenorphine, Quantitative, Urine
93031
Buprenorphine and Metabolites, LC/MS/MS, Serum
93790
Buprenorphine and Metabolite - Total (Qualitative), Meconium
BPRU
Buprenorphine
2968
BUN/Creatinine Ratio with eGFR [296X]
38410
Bumble Bee Venom (
Bombus terrestris
) (i205) IgE
16136
Bullous Pemphigoid BP230 Antibody
16034
Bullous Pemphigoid BP180 Antibody
28118
Buckwheat (f11) IgE [2811X]
PREV
1 of 80
2 of 80
3 of 80
4 of 80
5 of 80
6 of 80
7 of 80
8 of 80
9 of 80
10 of 80
11 of 80
12 of 80
13 of 80
14 of 80
15 of 80
16 of 80
17 of 80
18 of 80
19 of 80
20 of 80
21 of 80
22 of 80
23 of 80
24 of 80
25 of 80
26 of 80
27 of 80
28 of 80
29 of 80
30 of 80
31 of 80
32 of 80
33 of 80
34 of 80
35 of 80
36 of 80
37 of 80
38 of 80
39 of 80
40 of 80
41 of 80
42 of 80
43 of 80
44 of 80
45 of 80
46 of 80
47 of 80
48 of 80
49 of 80
50 of 80
51 of 80
52 of 80
53 of 80
54 of 80
55 of 80
56 of 80
57 of 80
58 of 80
59 of 80
60 of 80
61 of 80
62 of 80
63 of 80
64 of 80
65 of 80
66 of 80
67 of 80
68 of 80
69 of 80
70 of 80
71 of 80
72 of 80
73 of 80
74 of 80
75 of 80
76 of 80
77 of 80
78 of 80
79 of 80
80 of 80
NEXT
